These included, for instance, lower use of core biopsy and higher reporting of tumor grade, ER/PgR expression, and HER2 amplification, pathological stage, and distance to the nearest radial margin in noninvasive cancers in general hospitals compared to oncology centers. This evidence concerns the gene ESR1 and cancer.